Cargando…
Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab: A case report
Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who...
Autores principales: | Murayama, Yoshiaki, Ishimine, Tomohiko, Sasano, Mikio, Todaka, Takafumi, Matsumoto, Takashi, Shimabukuro, Taiga, Yonaha, Risa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981263/ https://www.ncbi.nlm.nih.gov/pubmed/36896031 http://dx.doi.org/10.1016/j.idcr.2023.e01727 |
Ejemplares similares
-
Ceftriaxone/dexamethasone/tocilizumab: Meningitis and spesis due to streptococcus pneumoniae infection and lack of efficacy: case report
Publicado: (2022) -
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
por: Hong, Jin Yeong, et al.
Publicado: (2022) -
Pneumococcal Meningitis
por: Di Dier, Kelly, et al.
Publicado: (2022) -
Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021) -
Pneumococcic Meningitis and Meningismus
Publicado: (1914)